Literature DB >> 32454746

Some New Hydrazone Derivatives Bearing the 1,2,4-Triazole Moiety as Potential Antimycobacterial Agents.

Keriman Özadali Sari1, Oya Ünsal Tan1, Dharmarajan Sriram2, Ayla Balkan1.   

Abstract

OBJECTIVES: The aim of this study was to synthesize, characterize, and screen some new 1-(4-((2-(4-substitutedphenyl)hydrazono)methyl)phenyl)-1H-1,2,4-triazole derivatives for their antimycobacterial activities.
MATERIALS AND METHODS: The target compounds (2a-h) were gained by condensation of 4-(1H-1,2,4-triazol-1-yl)benzaldehyde with appropriate phenylhydrazines. Their structures were elucidated by IR, 1H-NMR, and mass spectrometry. The antimycobacterial activities of the compounds were determined in vitro against Mycobacterium tuberculosis H37Rv.
RESULTS: The biological assay results showed that the methylsulfonyl-substituted derivative 2f displayed the highest antimycobacterial activity in this series.
CONCLUSION: Although the methylsulfonyl-substituted derivative exhibited significant antimycobacterial activity, none of the synthesized compounds was as effective as isoniazid, rifampin, ethambutol, and ciprofloxacin against M. tuberculosis. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  1; 2; 4-triazole; Hydrazone; antimycobacterial activity

Year:  2019        PMID: 32454746      PMCID: PMC7227891          DOI: 10.4274/tjps.galenos.2018.43660

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  23 in total

1.  Ultrasound effect on the aromatic nucleophilic substitution reactions on some haloarenes.

Authors:  Mária Meciarová; Stefan Toma; Peter Magdolen
Journal:  Ultrason Sonochem       Date:  2003-07       Impact factor: 7.491

2.  Total synthesis of mycocyclosin.

Authors:  James R Cochrane; Jonathan M White; Uta Wille; Craig A Hutton
Journal:  Org Lett       Date:  2012-04-20       Impact factor: 6.005

Review 3.  Chemotherapy and diagnosis of tuberculosis.

Authors:  Cesare Saltini
Journal:  Respir Med       Date:  2006-12       Impact factor: 3.415

4.  Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.

Authors:  Zahoor Ahmad; Sadhna Sharma; G K Khuller; Pushpendra Singh; Jaya Faujdar; V M Katoch
Journal:  Int J Antimicrob Agents       Date:  2006-11-13       Impact factor: 5.283

5.  Counting pyrazinamide in regimens for multidrug-resistant tuberculosis.

Authors:  Molly F Franke; Mercedes C Becerra; Dylan B Tierney; Michael L Rich; Cesar Bonilla; Jaime Bayona; Megan M McLaughlin; Carole D Mitnick
Journal:  Ann Am Thorac Soc       Date:  2015-05

6.  High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.

Authors:  C Kuaban; J Noeske; H L Rieder; N Aït-Khaled; J L Abena Foe; A Trébucq
Journal:  Int J Tuberc Lung Dis       Date:  2015-05       Impact factor: 2.373

7.  Tuberculosis success.

Authors:  Dan Jones
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

8.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.

Authors:  L Collins; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 9.  Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.

Authors:  Robert S Wallis; Markus Maeurer; Peter Mwaba; Jeremiah Chakaya; Roxana Rustomjee; Giovanni Battista Migliori; Ben Marais; Marco Schito; Gavin Churchyard; Soumya Swaminathan; Michael Hoelscher; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2016-04       Impact factor: 25.071

Review 10.  Clinical implications of the global multidrug-resistant tuberculosis epidemic.

Authors:  Kartik Kumar; Ibrahim Abubakar
Journal:  Clin Med (Lond)       Date:  2015-12       Impact factor: 2.659

View more
  1 in total

1.  Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking.

Authors:  Maged A El Sawy; Maram M Elshatanofy; Yeldez El Kilany; Kamal Kandeel; Bassma H Elwakil; Mohamed Hagar; Mohamed Reda Aouad; Fawzia Faleh Albelwi; Nadjet Rezki; Mariusz Jaremko; El Sayed H El Ashry
Journal:  Int J Mol Sci       Date:  2022-04-24       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.